1. Home
  2. COUR vs ENOV Comparison

COUR vs ENOV Comparison

Compare COUR & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COUR
  • ENOV
  • Stock Information
  • Founded
  • COUR 2012
  • ENOV 1995
  • Country
  • COUR United States
  • ENOV United States
  • Employees
  • COUR N/A
  • ENOV N/A
  • Industry
  • COUR Computer Software: Prepackaged Software
  • ENOV Fluid Controls
  • Sector
  • COUR Technology
  • ENOV Industrials
  • Exchange
  • COUR Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • COUR 1.8B
  • ENOV 1.8B
  • IPO Year
  • COUR 2021
  • ENOV 2008
  • Fundamental
  • Price
  • COUR $9.81
  • ENOV $30.36
  • Analyst Decision
  • COUR Buy
  • ENOV Strong Buy
  • Analyst Count
  • COUR 14
  • ENOV 6
  • Target Price
  • COUR $11.59
  • ENOV $51.00
  • AVG Volume (30 Days)
  • COUR 2.7M
  • ENOV 819.9K
  • Earning Date
  • COUR 10-23-2025
  • ENOV 11-05-2025
  • Dividend Yield
  • COUR N/A
  • ENOV N/A
  • EPS Growth
  • COUR N/A
  • ENOV N/A
  • EPS
  • COUR N/A
  • ENOV N/A
  • Revenue
  • COUR $721,674,000.00
  • ENOV $2,189,576,000.00
  • Revenue This Year
  • COUR $9.31
  • ENOV $9.13
  • Revenue Next Year
  • COUR $5.64
  • ENOV $6.39
  • P/E Ratio
  • COUR N/A
  • ENOV N/A
  • Revenue Growth
  • COUR 7.10
  • ENOV 14.40
  • 52 Week Low
  • COUR $5.76
  • ENOV $25.47
  • 52 Week High
  • COUR $13.56
  • ENOV $49.83
  • Technical
  • Relative Strength Index (RSI)
  • COUR 32.07
  • ENOV 46.38
  • Support Level
  • COUR $11.43
  • ENOV $29.80
  • Resistance Level
  • COUR $12.32
  • ENOV $32.43
  • Average True Range (ATR)
  • COUR 0.47
  • ENOV 1.05
  • MACD
  • COUR -0.20
  • ENOV -0.12
  • Stochastic Oscillator
  • COUR 0.79
  • ENOV 21.35

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: